Catalyst Wire Dossier Catalyst Wire Dossier

favipravir

favipravir
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for favipravir, covering 2023-02-21 to 2023-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients [Phase 4]

See pricing